VICTOZA® 6 mg/mL contains liraglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist used to improve glycemic control in adults and certain pediatric patients with type 2 diabetes mellitus. It is supplied as a solution for injection in a pre-filled pen for subcutaneous administration.

Composition

• Active ingredient: Liraglutide
• Strength: 6 mg/mL
• Content per pen: 18 mg liraglutide in 3 mL solution
• Dosage form: Solution for injection
• Route of administration: Subcutaneous injection

Package Contents

• 1 pre-filled pen containing 3 mL solution
• Patient information leaflet
• Pen needles may be supplied separately depending on the market

Indications

VICTOZA is indicated for:

• Improving glycemic control in patients with type 2 diabetes mellitus
• Use in combination with diet and exercise
• Use alone or in combination with other antidiabetic medications when appropriate
• Reducing the risk of major cardiovascular events in certain adults with type 2 diabetes and established cardiovascular disease, according to approved prescribing information

Key Features

• Ready-to-use pre-filled injection pen
• No reconstitution required
• Adjustable dosing using the pen device
• Once-daily administration
• Supports blood glucose management through GLP-1 receptor activation
• May contribute to weight reduction in some patients

Administration

• Administered once daily by subcutaneous injection
• Injection sites include the abdomen, thigh, or upper arm
• Can be taken at any time of day, independent of meals
• Use according to the prescribing physician’s instructions

Storage

• Store refrigerated at 2°C–8°C before first use
• Do not freeze
• Protect from excessive heat and direct sunlight
• After first use, follow storage recommendations in the product information leaflet

Packaging

• Product: VICTOZA®
• Active Substance: Liraglutide
• Strength: 6 mg/mL
• Content: 3 mL (18 mg liraglutide)
• Presentation: 1 pre-filled pen

Manufacturer

• Novo Nordisk

Note: VICTOZA is a prescription medication and should be used only under the supervision of a qualified healthcare professional. Treatment should be combined with appropriate dietary management, physical activity, and regular monitoring of blood glucose levels.